At some point we just have to trust the company and assume that their pre-clinical work is valid. Although skepticism is a healthy thing when investing in stocks, this company has some very talented and peer-recognized professionals running the show who would have too much to lose if their publications were proven to be faked.
In the end, you have to do your own research and come to your own conclusions as to the validity of this company and the likelihood of its success but I haven't found anything during my due diligence that would lead me to believe everything is not on the up-and-up. Obviously, biotech investments carry high risk and there's no guarantee Invivo will be successful but that was true of many biotech companies that are successful.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.